Bayesian Capital Management’s CNO Financial Group CNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,374
Closed -$203K 798
2024
Q1
$203K Buy
+7,374
New +$199K 0.02% 652
2021
Q1
Sell
-13,500
Closed -$300K 558
2020
Q4
$300K Buy
+13,500
New +$275K 0.08% 303
2020
Q2
Sell
-10,200
Closed -$126K 558
2020
Q1
$126K Buy
+10,200
New +$167K 0.03% 652
2019
Q1
Sell
-15,100
Closed -$225K 581
2018
Q4
$225K Buy
+15,100
New +$275K 0.05% 486
2017
Q4
Sell
-15,700
Closed -$366K 575
2017
Q3
$366K Sell
15,700
-1,300
-8% -$29K 0.09% 326
2017
Q2
$355K Buy
+17,000
New +$351K 0.13% 240
2017
Q1
Sell
-45,086
Closed -$863K 447
2016
Q4
$863K Buy
+45,086
New +$775K 0.21% 169

Other funds holding CNO

Bayesian Capital Management's CNO Position: Q2 2024 in Review

Bayesian Capital Management sold out of CNO Financial Group (CNO) in Q2 2024, closing a stake of 7,374 shares — an estimated $203K sold.

Bayesian Capital Management first reported a position in CNO in Q4 2016 and held it in 7 quarters. The position peaked at $863K in Q4 2016. 291 funds tracked by Wall St. Rank hold CNO as of Q2 2024.

  • Bayesian Capital Management reported no remaining CNO Financial Group position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 7,374 CNO Financial Group shares in Q2 2024, an estimated $203K.
  • Bayesian Capital Management first reported a position in CNO Financial Group in Q4 2016 and held it in 7 quarters.
  • Bayesian Capital Management's CNO Financial Group position peaked at $863K in Q4 2016.
  • 291 funds tracked by Wall St. Rank held CNO Financial Group as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.